Search Results - "PENGO, Vittorio"

Chronic Thromboembolic Pulmonary Hypertension by Kim, Nick H., MD, Delcroix, Marion, MD, Jenkins, David P., MB BS, Channick, Richard, MD, Dartevelle, Philippe, MD, Jansa, Pavel, MD, Lang, Irene, MD, Madani, Michael M., MD, Ogino, Hitoshi, MD, PhD, Pengo, Vittorio, MD, Mayer, Eckhard, MD

“…Since the last World Symposium on Pulmonary Hypertension in 2008, we have witnessed numerous and exciting developments in chronic thromboembolic pulmonary…”
Get full text

Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension　― A Systematic Review and Meta-Analysis by Zoppellaro, Giacomo, Badawy, Mostafa Rabea, Squizzato, Alessandro, Denas, Gentian, Tarantini, Giuseppe, Pengo, Vittorio

“…Background:Balloon pulmonary angioplasty (BPA) is a percutaneous treatment option for patients affected by chronic thromboembolic pulmonary hypertension…”
Get full text

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study by Pengo, Vittorio, Ruffatti, Amelia, Legnani, Cristina, Testa, Sophie, Fierro, Tiziana, Marongiu, Francesco, De Micheli, Valeria, Gresele, Paolo, Tonello, Marta, Ghirarduzzi, Angelo, Bison, Elisa, Denas, Gentian, Banzato, Alessandra, Padayattil Jose, Seena, Iliceto, Sabino

“…Persistent antiphospholipid (aPL) antibodies are occasionally found in subjects without prior history of thromboembolic events (TEs), raising the dilemma of…”
Get full text

A Novel ELISA Assay for the Detection of Anti-Prothrombin Antibodies in Antiphospholipid Syndrome Patients at High Risk of Thrombosis by Chinnaraj, Mathivanan, Pengo, Vittorio, Pozzi, Nicola

“…Autoantibodies targeting prothrombin (aPT) can be found in antiphospholipid syndrome (APS) patients. However, their detection has proven difficult to…”
Get full text

Preliminary hemocompatibility assessment of an innovative material for blood contacting surfaces by Todesco, Martina, Pontara, Elena, Cheng, Chunyan, Gerosa, Gino, Pengo, Vittorio, Bagno, Andrea

“…Over the years, several devices have been created (and the development of many others is currently in progress) to be in permanent contact with blood:…”
Get full text

Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study by Ruffatti, Amelia, Del Ross, Teresa, Ciprian, Manuela, Bertero, Maria T, Sciascia, Savino, Salvatore, Sciascia, Scarpato, Salvatore, Montecucco, Carlomaurizio, Rossi, Silvia, Caramaschi, Paola, Biasi, Domenico, Doria, Andrea, Rampudda, Mariaelisa, Monica, Nuzzo, Fischetti, Fabio, Picillo, Ugo, Brucato, Antonio, Salvan, Elisa, Vittorio, Pengo, Meroni, Pierluigi, Tincani, Angela

“…To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic…”
Get more information

Platelet- and endothelial-derived microparticles in the context of different antiphospholipid antibody profiles by Cheng, Chunyan, Bison, Elisa, Pontara, Elena, Cattini, Maria Grazia, Tonello, Marta, Denas, Gentian, Pengo, Vittorio

“…Objectives Studies on microparticles (MPs) in patients with antiphospholipid antibodies (aPL) are sparse and inconclusive. The relation between MPs and…”
Get full text

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome by Hoxha, Ariela, Mattia, Elena, Tonello, Marta, Grava, Chiara, Pengo, Vittorio, Ruffatti, Amelia

“…Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort…”
Get more information

COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study by Palareti, Gualtiero, Legnani, Cristina, Poli, Daniela, Ageno, Walter, Pengo, Vittorio, Testa, Sophie, Tosetto, Alberto, Prandoni, Paolo

Get full text

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients by Prandoni, Paolo, Noventa, Franco, Ghirarduzzi, Angelo, Pengo, Vittorio, Bernardi, Enrico, Pesavento, Raffaele, Iotti, Matteo, Tormene, Daniela, Simioni, Paolo, Pagnan, Antonio

“…From the Department of Medical and Surgical Sciences (PP, EB, PS, RP, DT, AP), Department of Clinical and Experimental Medicine, Group of Clinical Epidemiology…”
Get full text

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry by Marcucci, Rossella, Patti, Giuseppe, Calabrò, Paolo, Gori, Anna Maria, Grossi, Guido, Cirillo, Plinio, Pengo, Vittorio, Gresele, Paolo, Pignatelli, Pasquale, Antonucci, Emilia, di Mario, Carlo, Valente, Serafina, Palareti, Gualtiero

“…Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and…”
Get full text

Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history by Simioni, Paolo, Pengo, Vittorio, Prandoni, Paolo

“…The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and…”
Get full text

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry by Gresele, Paolo, Guglielmini, Giuseppe, Del Pinto, Maurizio, Calabrò, Paolo, Pignatelli, Pasquale, Patti, Giuseppe, Pengo, Vittorio, Antonucci, Emilia, Cirillo, Plinio, Fierro, Tiziana, Palareti, Gualtiero, Marcucci, Rossella

“…Some previous observations suggest that a low platelet count is associated with an increased risk of adverse outcomes in patients with acute coronary syndromes…”
Get full text

Antibody profiles for the diagnosis of antiphospholipid syndrome by Pengo, Vittorio, Biasiolo, Alessandra, Pegoraro, Cinzia, Cucchini, Umberto, Noventa, Franco, Iliceto, Sabino

“…Among the so called 'antiphospholipid antibodies', the presence of Lupus Anticoagulant (LA) is associated with thrombosis-related events and defines the…”
Get more information

Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism by Pengo, Vittorio, Lensing, Anthonie W.A, Prins, Martin H, Marchiori, Antonio, Davidson, Bruce L, Tiozzo, Francesca, Albanese, Paolo, Biasiolo, Alessandra, Pegoraro, Cinzia, Iliceto, Sabino, Prandoni, Paolo

“…Chronic thromboembolic pulmonary hypertension is believed to be rare after an episode of acute pulmonary embolism. This study showed that the incidence of this…”
Get full text

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register by Palareti, Gualtiero, Legnani, Cristina, Antonucci, Emilia, Cosmi, Benilde, Falanga, Anna, Poli, Daniela, Mastroiacovo, Daniela, Pengo, Vittorio, Ageno, Walter, Testa, Sophie

“…Background: Venous thromboembolism (VTE) is a frequent and serious disease that requires immediate and long-term anticoagulant treatment, which is inevitably…”
Get full text

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome by Patti, Giuseppe, Cavallari, Ilaria, Antonucci, Emilia, Calabrò, Paolo, Cirillo, Plinio, Gresele, Paolo, Palareti, Gualtiero, Pengo, Vittorio, Pignatelli, Pasquale, Ricottini, Elisabetta, Marcucci, Rossella

“…There are limited real-world data on prevalence and predictors of dual antiplatelet therapy (DAPT) prolongation beyond one year after acute coronary syndrome…”
Get full text

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study by Cosmi, Benilde, Legnani, Cristina, Tosetto, Alberto, Pengo, Vittorio, Ghirarduzzi, Angelo, Testa, Sophie, Prisco, Domenico, Poli, Daniela, Tripodi, Armando, Marongiu, Francesco, Palareti, Gualtiero

“…The PROLONG randomized trial showed that a normal D-dimer (D-d) 1 month after anticoagulation suspension for unprovoked venous thromboembolism (VTE) was…”
Get full text

Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation by Ferroni, Eliana, Denas, Gentian, Gennaro, Nicola, Fedeli, Ugo, Pengo, Vittorio

“…Background: DOACs are characterized by a higher incidence of gastrointestinal bleeding and this may be different among males and females. Female patients were…”
Get full text

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies by Lazzaroni, Maria-Grazia, Fredi, Micaela, Andreoli, Laura, Chighizola, Cecilia Beatrice, Del Ross, Teresa, Gerosa, Maria, Kuzenko, Anna, Raimondo, Maria-Gabriella, Lojacono, Andrea, Ramazzotto, Francesca, Zatti, Sonia, Trespidi, Laura, Meroni, Pier-Luigi, Pengo, Vittorio, Ruffatti, Amelia, Tincani, Angela

“…Antiphospholipid antibodies (aPL) are risk factors for thrombosis and adverse pregnancy outcomes (APO). The management of the so called "aPL carriers"…”
Get full text